The Global Electrophoresis Market, by Product (Systems, Reagents, Software, and Others), by Application (Diagnosis, Pharmaceutical & Biotechnology Research, and Others), by End Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
was valued at US$ 2,263.3 million
in 2017, and is projected to exhibit a CAGR of 5.7%
over the forecast period (2018 - 2026), as highlighted in a new report published by .
Electrophoresis is important for the study of DNA and RNA separation. Various kinds of electrophoresis are available in the market, among which gel electrophoresis is one of the most common for laboratory applications. It is used to separate the biomolecules in nucleic acids and proteins in a gel after being exposed to a field of electricity. Demand for technologically advanced electrophoresis is rising with the increasing R&D investments by various public and private firms in order to develop new medicines, vaccines, and diagnostic tools.
Introduction of technologically advanced design of electrophoresis enable laboratory technicians to perform the process more efficiently with less time. For instance, advanced labs use gel solutions as the conductor for the electrical charge, which offers quick and easy separation of particles. Moreover, with the development of increased sensitivity in detection systems, it is possible to increase the speed and processing of electrophoresis.
Manufacturers in the electrophoresis market are focusing on strategic partnerships and development of low cost and highly efficient products in order to increase the sale of their products eventually driving growth of the electrophoresis market. For instance, in 2017, Thermo Fisher Scientific launched a new Capillary Electrophoresis (CE) system designed to offer a low-throughput, cartridge-based system for Sanger sequencing and fragment analysis. The new CE system reduces the cost of capillary electrophoresis platforms and is very simple to operate. In May 2018, Agilent Technologies, Inc. acquired Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) solutions for fully-automated analysis of a range of molecules for US$ 250 million in cash.
Browse 36 Market Data Tables and 28 Figures spread through 170 Pages and in-depth TOC on "Electrophoresis Market, by Product (Systems, Reagents, Software, and Others), by Application (Diagnosis, Pharmaceutical & Biotechnology Research, and Others), by End Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to electrophoresis market, click the link below:
Key Takeaways of the Electrophoresis Market:
- The global electrophoresis market is expected to expand at a CAGR of 5.7% during the forecast period (2018–2026), owing to increasing R&D in pharmaceutical and biotechnology industry. For instance, according to the 13th five year plan for national science and technology talent development (2016-2020), China will increase its annual per capita spending on R&D to US$ 79,442 by 2020, up from US$ 58,787 in 2014.
- Among end use, the academic & research institutes segment is expected to generate significant revenue during the forecast period, owing to rise in the number of biotechnology and life science research studies globally coupled with increasing R&D spending.
- Major players operating in the global electrophoresis market include Agilent Technologies, Bio-Rad Laboratories, C.B.S. Scientific Company, Inc., Danaher Corporation, GE Healthcare, Harvard Bioscience, Inc., Hoefer Inc., Lonza Group Ltd., Merck Millipore, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., and Qiagen N.V.